Work

Pd60-01 Castrate Resistant Tmprss2: Erg Fusion Positive and Tmprss2: Erg Wild Type Refractory Acinar and Neuroendocrine Prostate Cancer Differ in Genomic Signatures and Opportunities for Targeted and Immunotherapies

Year: 2018

Type: article

Source: The Journal of Urology

DOI: 10.1016/j.juro.2018.02.2813

Authors: Nick Liu, Hugh A.G. Fisher, Timothy Byler, Joseph Jacob, Jon Chung, Julia Andrea Elvin, Jo-Anne Vergilio, Shakti Ramkissoon, James Suh, Eric Allan Severson, Sugganth Daniel, Siraj Mahamed Ali, Alexa Betzig Schrock, Vincent A. Miller, Philip J. Stephens, Laurie M. Gay, Leszek Kotula, Jeffrey S. Ross, Gennady Bratslavsky

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2796348771

FWCI:

Cites:

Cited by:

Related to: 10